美国 · SEC FORM 4
CASSAVA SCIENCES INC
SAVA · Nasdaq · CIK 0001069530 · Healthcare
内部人信号
3 qualifying P purchase groups
当前 180 天评分窗口
3 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: President & CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-09-30 · Barry Richard.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Barry Richard | 买入 (P) | Common Stock | 100,000 | USD 0.92 | USD 92,000 | SEC 申报 ↗ |
| 2026-09-29 | Barry Richard | 买入 (P) | Common Stock | 206,813 | USD 0.90 | USD 186,132 | SEC 申报 ↗ |
| 2026-09-28 | Barry Richard | 买入 (P) | Common Stock | 93,091 | USD 0.84 | USD 78,196 | SEC 申报 ↗ |
| 2025-11-24 | Anderson Robert Eugene Jr | 买入 (P) | Common Stock | 8,600 | USD 2.90 | USD 24,940 | SEC 申报 ↗ |
| 2025-11-20 | Barry Richard | 买入 (P) | Common Stock | 150,000 | USD 2.76 | USD 414,000 | SEC 申报 ↗ |
| 2025-11-19 | Barry Richard | 买入 (P) | Common Stock | 73,385 | USD 2.75 | USD 201,809 | SEC 申报 ↗ |
| 2025-09-30 | Cook Robert Christopher | 买入 (P) | Common Stock | 13,725 | USD 2.91 | USD 39,940 | SEC 申报 ↗ |
| 2025-09-22 | Barry Richard | 买入 (P) | Common Stock | 7,172 | USD 2.28 | USD 16,352 | SEC 申报 ↗ |
| 2025-09-19 | Barry Richard | 买入 (P) | Common Stock | 47,308 | USD 2.29 | USD 108,319 | SEC 申报 ↗ |
| 2025-09-18 | Barry Richard | 买入 (P) | Common Stock | 190,633 | USD 2.24 | USD 426,424 | SEC 申报 ↗ |
| 2023-08-23 | ROBERTSON SANFORD | 买入 (P) | Common Stock | 30,000 | USD 17.45 | USD 523,500 | SEC 申报 ↗ |
| 2023-08-22 | Barry Richard | 买入 (P) | Common Stock | 16,571 | USD 16.65 | USD 275,907 | SEC 申报 ↗ |
| 2023-08-21 | Barry Richard | 买入 (P) | Common Stock | 1,906 | USD 16.80 | USD 32,021 | SEC 申报 ↗ |
| 2023-03-07 | Barry Richard | 买入 (P) | Common Stock | 77,276 | USD 25.76 | USD 1,990,630 | SEC 申报 ↗ |
| 2023-03-06 | Barry Richard | 买入 (P) | Common Stock | 11,565 | USD 26.13 | USD 302,193 | SEC 申报 ↗ |
Form 4 申报证据
6 transaction lines in the latest 365-day window; 81 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Barry Richard | 买入 (P) | Common Stock | 100,000 | USD 0.92 | USD 92,000 | SEC 申报 ↗ |
| 2026-09-29 | Barry Richard | 买入 (P) | Common Stock | 206,813 | USD 0.90 | USD 186,132 | SEC 申报 ↗ |
| 2026-09-28 | Barry Richard | 买入 (P) | Common Stock | 93,091 | USD 0.84 | USD 78,196 | SEC 申报 ↗ |
展开近期 Form 4 证据 (6 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Barry Richard | 买入 (P) | Common Stock | 100,000 | USD 0.92 | USD 92,000 | SEC 申报 ↗ |
| 2026-09-29 | Barry Richard | 买入 (P) | Common Stock | 206,813 | USD 0.90 | USD 186,132 | SEC 申报 ↗ |
| 2026-09-28 | Barry Richard | 买入 (P) | Common Stock | 93,091 | USD 0.84 | USD 78,196 | SEC 申报 ↗ |
| 2025-11-24 | Anderson Robert Eugene Jr | 买入 (P) | Common Stock | 8,600 | USD 2.90 | USD 24,940 | SEC 申报 ↗ |
| 2025-11-20 | Barry Richard | 买入 (P) | Common Stock | 150,000 | USD 2.76 | USD 414,000 | SEC 申报 ↗ |
| 2025-11-19 | Barry Richard | 买入 (P) | Common Stock | 73,385 | USD 2.75 | USD 201,809 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SAVA |
| CIK | 0001069530 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 81 transaction lines from 2020-09-17 to 2026-09-30 26 P purchase lines · 3 S sale lines · 52 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.